Total Payments
$472,029
2024 Payments
$589.86
Companies
21
Transactions
92
Medicare Patients
1,817
Medicare Billing
$141,937
Payment Breakdown by Category
Research$416,065 (88.1%)
Consulting$33,960 (7.2%)
Other$11,990 (2.5%)
Travel$6,523 (1.4%)
Food & Beverage$3,490 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $416,065 | 4 | 88.1% |
| Consulting Fee | $33,960 | 12 | 7.2% |
| Honoraria | $10,590 | 2 | 2.2% |
| Travel and Lodging | $6,523 | 27 | 1.4% |
| Food and Beverage | $3,490 | 46 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,400 | 1 | 0.3% |
Payments by Type
Research
$416,065
4 transactions
General
$55,964
88 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $414,665 | 3 | $0 (2017) |
| Biom'Up France SAS | $9,000 | 3 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $7,360 | 6 | $0 (2019) |
| Ferring Inc. | $6,721 | 5 | $0 (2019) |
| UroGen Pharma, Inc. | $6,458 | 2 | $0 (2022) |
| Medtronic, Inc. | $6,122 | 32 | $0 (2022) |
| Seagen Inc. | $5,170 | 3 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $3,840 | 1 | $0 (2019) |
| Janssen Research & Development, LLC | $3,575 | 3 | $0 (2023) |
| EISAI INC. | $3,500 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $589.86 | 12 | TerSera Therapeutics LLC ($589.86) |
| 2023 | $952.32 | 4 | Janssen Research & Development, LLC ($715.00) |
| 2022 | $11,882 | 37 | Medtronic, Inc. ($5,742) |
| 2021 | $19,945 | 9 | Biom'Up France SAS ($6,750) |
| 2020 | $3,755 | 4 | Biom'Up France SAS ($2,250) |
| 2019 | $19,590 | 16 | Ferring Pharmaceuticals Inc. ($7,360) |
| 2018 | $229.55 | 3 | Dendreon Pharmaceuticals LLC ($128.66) |
| 2017 | $415,085 | 7 | Valeant Pharmaceuticals North America LLC ($414,665) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $103.50 | General |
| Category: Oncology | ||||||
| 12/05/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Oncology | ||||||
| 12/04/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $166.94 | General |
| Category: Oncology | ||||||
| 11/05/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Oncology | ||||||
| 10/16/2024 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $82.87 | General |
| 09/16/2024 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $6.19 | General |
| 08/26/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $4.76 | General |
| Category: Oncology | ||||||
| 05/02/2024 | TerSera Therapeutics LLC | — | Food and Beverage | In-kind items and services | $15.75 | General |
| 04/22/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $9.47 | General |
| Category: Oncology | ||||||
| 03/20/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $35.96 | General |
| Category: Oncology | ||||||
| 01/26/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $121.40 | General |
| Category: Oncology | ||||||
| 01/25/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Oncology | ||||||
| 04/10/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $715.00 | General |
| 04/03/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: LithoVue_URO | ||||||
| 04/03/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $35.37 | General |
| Category: LithoVue_URO | ||||||
| 04/02/2023 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $76.95 | General |
| Category: Diagnostic Imaging | ||||||
| 12/05/2022 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Oncology | ||||||
| 11/08/2022 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $235.10 | General |
| 11/05/2022 | Medtronic, Inc. | VALLEYLAB FT10 (Device) | Food and Beverage | In-kind items and services | $128.30 | General |
| Category: Electrosurgical Products | ||||||
| 11/04/2022 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $338.00 | General |
| 11/04/2022 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $58.81 | General |
| 11/02/2022 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $215.24 | General |
| 10/23/2022 | Medtronic, Inc. | ENDO GIA ULTRA (Device) | Food and Beverage | In-kind items and services | $40.86 | General |
| Category: Surgical Stapling | ||||||
| 10/21/2022 | Medtronic, Inc. | — | Travel and Lodging | In-kind items and services | $351.00 | General |
| 10/21/2022 | Medtronic, Inc. | ENDO GIA ULTRA (Device) | Food and Beverage | In-kind items and services | $104.61 | General |
| Category: Surgical Stapling | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| IISInman-George | Valeant Pharmaceuticals North America LLC | $276,444 | 2 |
| IIS InmanGeorge | Valeant Pharmaceuticals North America LLC | $138,222 | 1 |
| AXITINIB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $1,400 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 184 | 202 | $67,362 | $9,715 |
| 2022 | 11 | 542 | 708 | $287,777 | $43,887 |
| 2021 | 11 | 525 | 704 | $310,805 | $43,870 |
| 2020 | 12 | 566 | 775 | $330,823 | $44,465 |
Total Patients
1,817
Total Services
2,389
Medicare Billing
$141,937
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 99 | 111 | $19,092 | $4,629 | 24.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 60 | 65 | $38,350 | $2,975 | 7.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $6,860 | $1,480 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 12 | $3,060 | $630.88 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 161 | 234 | $40,248 | $10,739 | 26.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 123 | 173 | $102,070 | $9,030 | 8.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 53 | 53 | $25,970 | $7,286 | 28.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 72 | 85 | $21,675 | $5,754 | 26.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $8,748 | $2,773 | 31.7% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2022 | 11 | 12 | $24,276 | $2,430 | 10.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 39 | 62 | $6,696 | $1,802 | 26.9% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 15 | 18 | $44,924 | $1,772 | 3.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 17 | 17 | $5,848 | $1,642 | 28.1% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2022 | 19 | 22 | $2,156 | $423.88 | 19.7% |
| 51720 | Instillation of anti-cancer drug into bladder | Facility | 2022 | 14 | 14 | $5,166 | $235.70 | 4.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 181 | 273 | $46,956 | $12,504 | 26.6% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 127 | 182 | $107,380 | $9,519 | 8.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 63 | 63 | $30,870 | $8,301 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 48 | 53 | $13,515 | $3,922 | 29.0% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 19 | 25 | $59,218 | $2,371 | 4.0% |
| 52235 | Destruction and/or removal of (2.0 to 5.0 centimeters) medium growths of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 12 | 12 | $24,276 | $2,229 | 9.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 11 | 12 | $4,128 | $1,378 | 33.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $3,608 | $1,188 | 32.9% |
| 52005 | Insertion of catheter into urinary duct (ureter) using an endoscope through the bladder area | Facility | 2021 | 17 | 17 | $15,096 | $1,100 | 7.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 27 | $2,916 | $806.49 | 27.7% |
About Dr. Brant Inman, M.D
Dr. Brant Inman, M.D is a Urology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093795429.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brant Inman, M.D has received a total of $472,029 in payments from pharmaceutical and medical device companies, with $589.86 received in 2024. These payments were reported across 92 transactions from 21 companies. The most common payment nature is "" ($416,065).
As a Medicare-enrolled provider, Inman has provided services to 1,817 Medicare beneficiaries, totaling 2,389 services with total Medicare billing of $141,937. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Durham, NC
- Active Since 01/20/2006
- Last Updated 08/27/2008
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1093795429
Products in Payments
- SIPULEUCEL-T (Drug) $414,665
- HEMOBLAST BELLOWS (Device) $6,750
- JELMYTO (Drug) $6,458
- PADCEV (Biological) $5,043
- OPDIVO (Biological) $3,840
- Lenvima (Drug) $3,500
- INLYTA (Drug) $2,800
- HemoBlast Bellows (Device) $2,250
- Cysview (Drug) $536.67
- Zoladex (Drug) $485.05
- LithoVue (Device) $326.78
- VERSAONE (Device) $188.84
- ENDO GIA ULTRA (Device) $145.47
- iTIND System (Device) $143.81
- TECENTRIQ (Biological) $128.91
- PROVENGE (Drug) $128.66
- VALLEYLAB FT10 (Device) $128.30
- LIGASURE (Device) $105.46
- GENERAL KIDNEY STONE DISEASE (Device) $100.60
- ShockPulse - SE (Device) $77.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Durham
Daniel George, M.d, M.D
Urology — Payments: $1.3M
Urology $1.3M
Judd Moul, M.d, M.D
Urology — Payments: $1.2M
Urology $1.2M
Glenn Preminger, M.d, M.D
Urology — Payments: $866,632
Urology $866,632
Dr. Michael Lipkin, Md, MD
Urology — Payments: $304,475
Urology $304,475
Mr. Jay Kim, Md, MD
Urology — Payments: $245,916
Urology $245,916
Dr. Andrew Peterson, Md, MD
Urology — Payments: $204,892
Urology $204,892